A mutation-led search for novel functional domains in MeCP2
Jacky GuyiD, Beatrice Alexander-HowdeniD, Laura FitzPatrickiD, Dina DeSousa, Martha V. KoerneriD, Jim SelfridgeiD, Adrian Peter BirdiD
Abstract
Most missense mutations causing Rett syndrome affect domains of MeCP2 that have been shown to either bind methylated DNA or interact with a transcriptional co-repressor complex. Several mutations, however, including the C-terminal truncations that account for ~10% of cases, fall outside these characterised domains. We studied the molecular consequences of four of these \"non-canonical\" mutations in cultured neurons and mice to see if they reveal additional essential domains without affecting known properties of MeCP2. The results show that the mutations partially or strongly deplete the protein and also in some cases interfere with co-repressor recruitment. These mutations therefore impact the activity of known functional domains and do not invoke new molecular causes of Rett syndrome. The finding that a stable C-terminal truncation does not compromise MeCP2 function raises the possibility that small molecules which stabilise these mutant proteins may be of therapeutic value.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 36
- FWCI
- 2.15
- Field percentile
- top 12%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuronal non-CG methylation is an essential target for MeCP2 function
Rebekah Tillotson, Justyna Cholewa-Waclaw, … Adrian Peter Bird·Molecular CellPeer-reviewed·Feb 8, 2021
- Suppressor mutations in Mecp2-null mice reveal that the DNA damage response is key to Rett syndrome pathology
Adebola Enikanolaiye, Julie Ruston, … Monica J. Justice·Genome ResearchPeer-reviewed·Apr 1, 2020
- Translational reading frame determines the pathogenicity of C-terminal frameshift deletions in MeCP2: an alternative therapeutic approach
Jacky Guy, Elena Hein, … Adrian Peter Bird·bioRxiv·Aug 31, 2025
- Structures of MeCP2 bound to nucleosomes reveal distinct mechanisms of Rett syndrome mutations
Liqi Yao, Carolina Valderrama-Hincapié, … Vignesh Kasinath·bioRxiv·Sep 11, 2026
- MeCP2 NID interaction with RNA: Implications for Rett Syndrome-Relevant Protein Regulation
Katrina Good, Hilmar Strickfaden, … Juan Ausió·Human Molecular GeneticsPeer-reviewed·Jan 1, 2026
- The role of N-terminal modification of MeCP2 in the pathophysiology of Rett syndrome
Taimoor I. Sheikh, Alexia Martínez de Paz, … John B. Vincent·Human Molecular GeneticsPeer-reviewed·Jul 26, 2017